MAPT and Alzheimer disease: In support of this hypothesis are data showing that acute inflammatory episodes with elevated tumor necrosis factor-α (eg, infection, injury) are predictive of cognitive decline in patients with AD37 and that some AD rodent models with increased systemic inflammation secondary to lipopolysaccharide administration show increased Aβ and tau pathology.38